Volume 11, Issue 4 (Vol.11 No.4 Jan 2023)                   rbmb.net 2023, 11(4): 553-564 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khosravi A, Deyhim M R, Yari F, Nikougoftar Zarif M. Resveratrol; a Double-Edged Sword Antioxidant Agent for Preserving Platelet Cell Functions During Storage; Molecular Insights. rbmb.net 2023; 11 (4) :553-564
URL: http://rbmb.net/article-1-948-en.html
Blood Transfusion Research center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Abstract:   (1632 Views)

Background: In the current study we have aimed to find the effects of Resveratrol treatment on platelet concentrates (PCs) at the dose dependent manner. We have also attempted to find the molecular mechanism of the effects.

Methods: The PCs, have received from Iranian blood transfusion organization (IBTO). Totally 10 PCs were studied. The PCs divided into 4 groups including untreated (control) and treated by different dose of Resveratrol; 10, 30 and 50 µM. Platelet aggregation and total reactive oxygen species (ROS) levels were evaluated at day 3 of PCs storage. In silico analysis was carried out to find out the potential involved mechanisms.

Results: The aggregation against collagen has fallen dramatically in all studied groups but at the same time, aggregation was significantly higher in the control versus treated groups (p<0.05). The inhibitory effect was dose dependent. The aggregation against Ristocetin did not significantly affect by Resveratrol treatment. The mean of total ROS significantly increased in all studied groups except those PCs treated with 10 µM of Resveratrol (P=0.9). The ROS level significantly increased with increasing Resveratrol concentration even more than control group (slope=11.6, P=0.0034). Resveratrol could potently interact with more than 15 different genes which, 10 of them enrolled in cellular regulation of the oxidative stress.

Conclusions: Our findings indicated that the Resveratrol affect the platelet aggregation at the dose dependent manner. Moreover, we have also found that the Resveratrol play as double-edged sword in the controlling oxidative state of the cells. Therefore, Using the optimal dose of Resveratrol is the great of importance.

Full-Text [PDF 321 kb]   (1228 Downloads)    
Type of Article: Original Article | Subject: Cell Biology
Received: 2022/05/17 | Accepted: 2022/06/13 | Published: 2023/04/3

1. Dhurat R, Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective. J Cutan Aesthet Surg. 2014;7(4):189. [DOI:10.4103/0974-2077.150734] [PMID] [PMCID]
2. Nasiri S. Conversion from platelet-rich plasma platelet production to buffy coat platelet component production: benefits and limitations. IJBC. 2014;6(4):189-202.
3. Shrivastava M. The platelet storage lesion. Transfus Apher Sci.2009;41(2):105-13. [DOI:10.1016/j.transci.2009.07.002] [PMID]
4. Aubron C, Flint AWJ, Ozier Y, McQuilten Z. Platelet storage duration and its clinical and transfusion outcomes: a systematic review. Crit Care. 2018;22(1):185. [DOI:10.1186/s13054-018-2114-x] [PMID] [PMCID]
5. Cauwenberghs S, van Pampus E, Curvers J, Akkerman JW, Heemskerk JW. Hemostatic and signaling functions of transfused platelets. Transfus Med Rev. 2007;21(4):287-94. [DOI:10.1016/j.tmrv.2007.05.004] [PMID]
6. Ohto H, Nollet KE. Overview on platelet preservation: better controls over storage lesion. Transfus Apher Sci. 2011;44(3):321-5. [DOI:10.1016/j.transci.2011.03.008] [PMID]
7. Springer DL, Miller JH, Spinelli SL, Pasa-Tolic L, Purvine SO, Daly DS, Zangar RC, et al. Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res. 2009;8(5):2261-72. [DOI:10.1021/pr800885j] [PMID] [PMCID]
8. Solheim BG, Flesland O, Seghatchian J, Brosstad F. Clinical implications of red blood cell and platelet storage lesions: an overview. Transfus Apher Sci. 2004;31(3):185-9. [DOI:10.1016/j.transci.2004.09.004] [PMID]
9. Aubron C, Flint AW, Ozier Y, McQuilten Z. Transfusion of stored platelets: balancing risks and product availability. Int J Clin Transfus Med. 2016;4:133-8. [DOI:10.2147/IJCTM.S98418]
10. Ng MSY, Tung JP, Fraser JF. Platelet Storage Lesions: What More Do We Know Now? Transfus Med Rev. 2018;32(3):144-154. [DOI:10.1016/j.tmrv.2018.04.001] [PMID]
11. Vit G, Klüter H, Wuchter P. Platelet storage and functional integrity. Journal of Laboratory Medicine. 2020;44(5):285-93. [DOI:10.1515/labmed-2020-0067]
12. Seghatchian J, Krailadsiri P. Platelet storage lesion and apoptosis: are they related? Transfus Apher Sci. 2001;24(1):103-5. [DOI:10.1016/S0955-3886(00)00134-X] [PMID]
13. Slichter SJ, Corson J, Jones MK, Christoffel T, Pellham E, Bailey SL, Bolgiano D. Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS). Blood. 2014;123(2):271-80. [DOI:10.1182/blood-2013-05-501247] [PMID] [PMCID]
14. Springer M, Moco S. Resveratrol and Its Human Metabolites-Effects on Metabolic Health and Obesity. Nutrients. 2019;11(1):143. [DOI:10.3390/nu11010143] [PMID] [PMCID]
15. Walzem RL, German JB. The French Paradox, in: Beverages in Nutrition and Health 2004 (31-48). Humana Press, Totowa, NJ. [DOI:10.1007/978-1-59259-415-3_3]
16. Bonnefont-Rousselot D. Resveratrol and Cardiovascular Diseases. Nutrients. 2016;8(5):250. [DOI:10.3390/nu8050250] [PMID] [PMCID]
17. Olas B, Wachowicz B. Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets. 2005;16(5):251-60. [DOI:10.1080/09537100400020591] [PMID]
18. Zbikowska HM, Olas B, Wachowicz B, Krajewski T. Response of blood platelets to resveratrol. Platelets. 1999;10(4):247-52. [DOI:10.1080/09537109976103] [PMID]
19. Wang Z, Huang Y, Zou J, Cao K, Xu Y, Wu JM. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med. 2002;9(1):77-9. [DOI:10.3892/ijmm.9.1.77] [PMID]
20. Mohammadi A, Balizadeh Karami AR, Dehghan Mashtani V, Sahraei T, Bandani Tarashoki Z, Khattavian E, Mobarak S, Moradi Kazerouni H, Radmanesh E. Evaluation of Oxidative Stress, Apoptosis, and Expression of MicroRNA-208a and MicroRNA-1 in Cardiovascular Patients. Rep Biochem Mol Biol. 2021;10(2):183-196. [DOI:10.52547/rbmb.10.2.183] [PMID] [PMCID]
21. Freshour SL, Kiwala S, Cotto KC, Coffman AC, McMichael JF, Song JJ, Griffith M, et al. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 2021;49(D1):D1144-D1151. [DOI:10.1093/nar/gkaa1084] [PMID] [PMCID]
22. Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605-D612. [DOI:10.1093/nar/gkaa1074] [PMID] [PMCID]
23. Moroff G, Chang CH. Aggregation response of human platelets stored at 22 C as platelet-rich plasma. Transfusion. 1979;19(6):704-18. [DOI:10.1046/j.1537-2995.1979.19680104096.x] [PMID]
24. Fiedler SA, Boller K, Junker AC, Kamp C, Hilger A, Schwarz W, et al. Evaluation of the in vitro Function of Platelet Concentrates from Pooled Buffy Coats or Apheresis. Transfus Med Hemother. 2020;47:314-24. [DOI:10.1159/000504917] [PMID] [PMCID]
25. Marini I, Aurich K, Jouni R, Nowak-Harnau S, Hartwich O, Greinacher A, et al. Cold storage of platelets in additive solution: the impact of residual plasma in apheresis platelet concentrates. Haematologica. 2019;104(1):207-214. [DOI:10.3324/haematol.2018.195057] [PMID] [PMCID]
26. Rosenfeld BA, Herfel B, Faraday N, Fuller A, Braine H. Effects of storage time on quantitative and qualitative platelet function after transfusion. Anesthesiology. 1995;83(6):1167-72. [DOI:10.1097/00000542-199512000-00006] [PMID]
27. Choi JW, Pai SH. Influence of storage temperature on the responsiveness of human platelets to agonists. Ann Clin Lab Sci. 2003;33(1):79-85.
28. Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost. 2001;86(1):189-97. [DOI:10.1055/s-0037-1616217] [PMID]
29. Hosseini E, Beshkar P, Ghasemzadeh M. Reverse correlations of collagen-dependent platelet aggregation and adhesion with GPVI shedding during storage. J Thromb Thrombolysis. 2018;46(4):534-540. [DOI:10.1007/s11239-018-1739-6] [PMID]
30. Hosseini E, Mohtashami M, Ghasemzadeh M. Down-regulation of platelet adhesion receptors is a controlling mechanism of thrombosis, while also affecting post-transfusion efficacy of stored platelets. Thromb J. 2019;17:20. [DOI:10.1186/s12959-019-0209-5] [PMID] [PMCID]
31. Pirmohammad Jamaat Z, Hosseini E, Ghasemzadeh M. The expression loss of GPIbα due to ectodomain shedding in PRP derived platelet concentrates during storage. Tehran University Medical Journal. 2016;74(2):92-8.
32. Kim H, Oh SJ, Liu Y, Lee MY. A comparative study of the anti-platelet effects of cis-and trans-Resveratrol. The Korean Society of Applied Pharmacology. 2011;19(2):201-5. [DOI:10.4062/biomolther.2011.19.2.201]
33. Sobotková A, Másová-Chrastinová L, Suttnar J, Stikarová J, Májek P, Reicheltová Z, et al. Antioxidants change platelet responses to various stimulating events. Free Radic Biol Med. 2009;47(12):1707-14. [DOI:10.1016/j.freeradbiomed.2009.09.015] [PMID] [PMCID]
34. Shen MY, Hsiao G, Liu CL, Fong TH, Lin KH, Chou DS, Sheu JR. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. Br J Haematol. 2007;139(3):475-85. [DOI:10.1111/j.1365-2141.2007.06788.x] [PMID]
35. Corona de la Peña N, Gutiérrez-Aguilar M, Hernández-Reséndiz I, Marín-Hernández Á, Rodríguez-Enríquez S. Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets. PLoS One. 2017;12(8):e0182374. [DOI:10.1371/journal.pone.0182374] [PMID] [PMCID]
36. Olas B, Zbikowska HM, Wachowicz B, Krajewski T, Buczyński A, Magnuszewska A. Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Pol. 1999;46(4):961-6. [DOI:10.18388/abp.1999_4119] [PMID]
37. Gresele P, Pignatelli P, Guglielmini G, Carnevale R, Mezzasoma AM, et al. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr. 2008;138(9):1602-8. [DOI:10.1093/jn/138.9.1602] [PMID]
38. Bosutti A, Degens H. The impact of resveratrol and hydrogen peroxide on muscle cell plasticity shows a dose-dependent interaction. Sci Rep. 2015 Jan 28;5:8093. [DOI:10.1038/srep08093] [PMID] [PMCID]
39. Lang F, Qin Z, Li F, Zhang H, Fang Z, Hao E. Apoptotic Cell Death Induced by Resveratrol Is Partially Mediated by the Autophagy Pathway in Human Ovarian Cancer Cells. PLoS One. 2015;10(6):e0129196. [DOI:10.1371/journal.pone.0129196] [PMID] [PMCID]
40. Ferber EC, Peck B, Delpuech O, Bell GP, East P, Schulze A. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ. 2012;19(6):968-79. [DOI:10.1038/cdd.2011.179] [PMID] [PMCID]
41. Asadi S, Rahimi Z, Saidijam M, Shabab N, Goodarzi MT. Effects of Resveratrol on FOXO1 and FOXO3a Genes Expression in Adipose Tissue, Serum Insulin, Insulin Resistance and Serum SOD Activity in Type 2 Diabetic Rats. Int J Mol Cell Med. 2018;7(3):176-184.
42. Hu Y, Pan H, Peng J, He J, Tang M, Yan S, et al. Resveratrol inhibits necroptosis by mediating the TNF-α/RIP1/RIP3/MLKL pathway in myocardial hypoxia/reoxygenation injury. Acta Biochim Biophys Sin (Shanghai). 2021;53(4):430-7. [DOI:10.1093/abbs/gmab012] [PMID]
43. Hussain AR, Uddin S, Bu R, Khan OS, Ahmed SO, Ahmed M, Al-Kuraya KS. Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines. PLoS One. 2011;6(9):e24703. [DOI:10.1371/journal.pone.0024703] [PMID] [PMCID]
44. Baghal-Sadriforoush S, Bagheri M, Abdi Rad I, Sotoodeh Nejadnematalahi F. PI3K Inhibition Sensitize the Cisplatin-resistant Human Ovarian Cancer Cell OVCAR3 by Induction of Oxidative Stress. Rep Biochem Mol Biol. 2022;10(4):675-685. [DOI:10.52547/rbmb.10.4.675] [PMID] [PMCID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2015 All Rights Reserved | Reports of Biochemistry and Molecular Biology

Designed & Developed by : Yektaweb